NEWAMSTERDAM PHARMA CO NV (NAMS) Stock Cash Flow
NASDAQ:NAMS - Nasdaq - NL00150012L7 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -78.05M | 4.18M | -126.81K | |||
| Depreciation Amortization | 72.00K | 14.00K | 1.00K | |||
| Change In Working Capital | 11.20M | 227.90K | -415.54K | |||
| Interest Paid | 262.00K | N/A | N/A | |||
| Other non cash items | 74.75M | -4.54M | 42.35K | |||
| OPERATING CASH FLOW | 7.97M | -138.38K | -500.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | -13.00K | -20.00K | -13.00K | |||
| Other Investing Activity | 728.00K | 0.00 | -138.00M | |||
| INVESTING CASH FLOW | 715.00K | 0.00 | -138.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | -65.00K | -10.00K | -82.91K | |||
| Stock Issued/Repurchased | 377.78M | 69.00M | 143.01M | |||
| Other Financing Activity | -2.53M | 0.00 | -3.06M | |||
| FINANCING CASH FLOW | 375.18M | 0.00 | 139.87M | |||
| Exchange Rate Effect | 1.57M | 1.43M | 24.00K | |||
| CHANGE IN CASH | 385.43M | -138.38K | 1.37M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | 7.97M | -138.38K | -500.00K | |||
| Capital Expenditure | -13.00K | -20.00K | -13.00K | |||
| FREE CASH FLOW | 7.96M | -138.38K | -500.00K | |||
All data in USD